

Cover Story
By Claire Dietz
If the June 22 Senate appropriations hearing is an indication, President Donald Trump will encounter considerable difficulty in accomplishing his stated goal of cutting the NIH budget by 21 percent in fiscal 2018.
By Matthew Bin Han Ong
In Brief
Drugs & Targets


Trending Stories
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- How George Tidmarsh crossed the FDA-industry Rubicon
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA













